Jim Cramer on Bristol-Myers Squibb: “The Stock’s Recent Pullbacks Have Represented Terrific Buying Opportunities”

Jim Cramer reviewed Bristol-Myers Squibb Company (NYSE:BMY) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. Cramer explained why the Charitable Trust owns the stock, as he remarked: Finally, there’s Bristol-Myers. Okay, this is a stock I like so much that we own it for the Charitable Trust. It was on a massive run from November through February, but then this month, it’s just, it stalled. Still, Bristol-Myers is up a quiet 28% since the end of October. In re ...